ResearcherFirst Affiliated Hospital of Harbin Medical UniversityNo recent work listed

Ziyi Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1528-3931; OpenAlex author ID A5100389142. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo. Co-author DOI 10.1248/bpb.b21-00353 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gang Tan · 1 shared paper, 2021 · strength 0.15
- Paper Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and… DOI 10.1248/bpb.b21-00353 ↗
Xueying Sun · 1 shared paper, 2021 · strength 0.15
- Paper Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and… DOI 10.1248/bpb.b21-00353 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.